Fisabio
Fisabio is a public non-profit foundation under the Generalitat Valenciana that coordinates biomedical and public health research across 173 research groups and four regional health departments, managing clinical trials, genomic surveillance, a biobank network, and a technology licensing portfolio for the Valencian Community.
- Company typePrivate
- Founded2008
- HeadquartersValencia, Spain
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Fisabio does
Fisabio (full legal name: Fundació per al Foment de la Investigació Sanitària i Biomèdica de la Comunitat Valenciana, in Spanish: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana) is a public non-profit foundation established in 2008 and headquartered in Valencia, Spain, operating under the Generalitat Valenciana's Conselleria de Sanitat. It functions as the centralized vehicle for healthcare and biomedical research promotion in the Valencian Community, coordinating 173 research groups, 939 research staff, 284 active projects, and 623 clinical trials across four health departments plus a dedicated Fisabio Public Health area. Its service portfolio includes technology licensing (29 patents), clinical trial management, public health surveillance (epidemiology, genomics, antimicrobial resistance monitoring), and a consolidated Research Portal. Technical infrastructure centers on a Massive Sequencing Service (NextSeq 500), a Bioinformatics Platform supporting the Research Portal, a Biosafety Level 3 laboratory, mass spectrometry, and an interoperability-managed Valencian Biobank Network. Operations are distributed across regional hospital sites in Valencia, Elche, Castellón, Alicante, Alzira, and Vila-real.
Revenue mechanics are non-commercial: Fisabio does not sell products to external customers. Funding flows from four streams — recurring institutional transfers from the Conselleria de Sanitat, FEDER co-financing (EU structural funds) for research infrastructure, PRTR NextGenEU recovery funds, and competitive national/international research grants (e.g., Instituto de Salud Carlos III, FECYT, IVACE+i). The foundation also generates modest technology-licensing income through its Innovation area. Leadership is constituted as a Patronato presided over by the regional Conseller de Sanitat, with María Luisa Caparrós Redondo serving as Directora Gerente (Managing Director).
Notable recent activity includes leadership of a European initiative on home care safety (2026), a joint decalogue with Universitat Jaume I on generative AI in care research (2026), and the EQUILAB wellbeing initiative (2026), alongside compliance with the Spanish Esquema Nacional de Seguridad and GDPR frameworks.
Fisabio firmographics
Firmographics- Name
- Fisabio
- Legal name
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio)
- Website
- https://fisabio.san.gva.es
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Fisabio is a public non-profit foundation under the Generalitat Valenciana that coordinates biomedical and public health research across 173 research groups and four regional health departments, managing clinical trials, genomic surveillance, a biobank network, and a technology licensing portfolio for the Valencian Community.
- Ownership category
- akta.pro rank
Fisabio industry classification
Industry- Product category
- Biomedical Research Services
- NAICS
- Public Administration (92)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Investigator & Site Training / GCP Support (HLAGACAF)
Keywords
Where Fisabio is headquartered
LocationHeadquarters
- HQ city
- Valencia
- HQ country
- Spain
- HQ region
- Europe
Offices6 records
Markets served
Fisabio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Public Institutional Funding: Core funding from the Generalitat Valenciana's Consellería de Sanitat for healthcare and biomedical research promotion in the Valencian Community
- European Regional Development Fund (FEDER): EU co-financing for research infrastructure, equipment, and innovation projects under the 2014-2020 operational program for Valencia
- PRTR NextGenEU Funding: Recovery and Resilience funds for research and innovation projects
- Competitive Research Grants: Project-based funding from national and international competitive calls for research projects
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Fisabio product offering
Product offeringCore offering
Fisabio operates as a multi-service biomedical and public health research foundation for the Valencian Community, providing technology licensing, clinical trial management, public health research, genomic sequencing, and a consolidated research portal that serves the regional healthcare system. Its offerings are delivered through institutional collaboration rather than commercial sales channels.
Product overview
Fisabio is a public foundation for health and biomedical research in the Valencian Community, Spain. It operates as a multi-service research organization offering technology licensing, clinical trial management, public health research, and a consolidated research portal. The foundation manages 173 research groups, 939 research staff, and 284 current projects. Its technology portfolio includes innovations available for licensing, while its research portal provides information consolidation for biomedical research management across the regional health system.
Differentiator
Problem solved
Functional benefit
Products and services
- Technology Portfolio and Licensing
Quantifiable outcome
- 284 active research projects across 173 research groups
- +2 more outcomes
Companies that use Fisabio
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles1 record
Fisabio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Fisabio partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Universitat Jaume IcoreAcademic research partner contributing to collaborative programs including AI in healthcare research and general biomedical collaboration
- Universitat de ValènciacoreUniversity partner represented on Fisabio's Board of Trustees (Patronato) through Carlos Hermenegildo Claudevilla
- Universidad Miguel Hernández d'ElxcoreUniversity partner represented on Fisabio's Board of Trustees through Antonio Miguel Picó Alfonso
- Valencian Community Biobank NetworkcoreNetwork of biobanks across the region with interoperability management system for biological sample sharing and research collaboration
- Laboratory Network for Antimicrobial Resistance SurveillancecoreRegional network for monitoring antimicrobial resistance with shared sequencing and laboratory equipment
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Fisabio competitors and assessment
Company assessmentDirect peers
- IRB Barcelona (Institute for Research in Biomedicine): Spanish biomedical research institute with strengths in computational biology, genomics, and structural biology; comparable to Fisabio's genomic and bioinformatics capabilities and its role as a regional research coordination entity.
- IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): Barcelona-based biomedical research foundation linked to Hospital Clínic that similarly coordinates clinical research across a hospital network, manages active trials, and operates as a centralized vehicle for regional health research — directly comparable in mandate and operating model to Fisabio.
- VHIO (Vall d'Hebron Institut d'Oncologia): Oncology-focused research foundation embedded within the Vall d'Hebron University Hospital in Barcelona; comparable as a hospital-anchored clinical research foundation with substantial trial activity and translational research programs.
- ISGlobal (Barcelona Institute for Global Health): Public-health-focused research institute with genomics and epidemiology capabilities; comparable to Fisabio-Salut Pública on outbreak surveillance, antimicrobial resistance, and population health research.
- CIBER (Centro de Investigación Biomédica en Red): Spanish national consortium of biomedical research groups organized into thematic areas; comparable to Fisabio in coordinating distributed research groups and clinical trial activity across multiple hospital sites.
- CRG (Centre for Genomic Regulation): Barcelona-based genomics and computational biology research institute; directly comparable to Fisabio's sequencing service and bioinformatics platform capabilities.
Others
- EATRIS (European Infrastructure for Translational Medicine): European distributed research infrastructure providing translational medicine services; comparable as an ecosystem participant in cross-border biomedical research coordination rather than a direct competitor.
Regional players
- Institut Pasteur: French biomedical research foundation with comparable multi-site research model, public health mandate, and infrastructure for infectious disease and genomic research; relevant as a comparable European public research foundation model.
Broad incumbents
- ISCIII (Instituto de Salud Carlos III): Spain's national public health research institute and a major funder of biomedical research; directly comparable as a public-sector research funder and operator, and an existing institutional partner of Fisabio.
- CNIO (Centro Nacional de Investigaciones Oncológicas): Spain's national cancer research centre; broader in scope and national in mandate, but comparable as a publicly funded biomedical research entity conducting translational and clinical research in a hospital-network-adjacent model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Fisabio social profiles
Digital presenceFisabio compliance and trust
Trust signalCompliance2 records
Fisabio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fisabio leadership team
Management profileNumber of profiles
Profiles1 record
Fisabio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fisabio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fisabio
What does Fisabio do?
Fisabio operates as a multi-service biomedical and public health research foundation for the Valencian Community, providing technology licensing, clinical trial management, public health research, genomic sequencing, and a consolidated research portal that serves the regional healthcare system. Its offerings are delivered through institutional collaboration rather than commercial sales channels.
Is Fisabio a public or private company?
Fisabio is a private company. It is classified as state government owned and is currently operating.
When was Fisabio founded?
Fisabio was founded in 2008. It employs 101 to 250 people.
Where is Fisabio based?
Fisabio is headquartered in Valencia, Spain, in the Europe region.
How does Fisabio make money?
Four revenue lines are on record. Public Institutional Funding is the primary driver. The others are european Regional Development Fund (FEDER), PRTR NextGenEU Funding and competitive Research Grants.
Who are Fisabio's main competitors?
Direct peers on record are IRB Barcelona (Institute for Research in Biomedicine), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), VHIO (Vall d'Hebron Institut d'Oncologia), ISGlobal (Barcelona Institute for Global Health), CIBER (Centro de Investigación Biomédica en Red) and CRG (Centre for Genomic Regulation). EATRIS (European Infrastructure for Translational Medicine) is listed as an others. Institut Pasteur is listed as a regional player. Broad incumbents are ISCIII (Instituto de Salud Carlos III) and CNIO (Centro Nacional de Investigaciones Oncológicas).
Does Fisabio have an API?
No public API is recorded for Fisabio.
What industry is Fisabio in?
Fisabio's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 92 and its SIC code is 8731.